CYTOKINE IMMUNITYINCKD PATIENTS TREATED WITH HD, HDF, PD

Abstract

Introduction. Cytokines play the corresponding role in the inflammatory processes and the development of endothelial dysfunction and therefore take an important place in the problem of systemic chronic inflammation (SCI) in patients with chronic kidney disease (CKD), stage V, who are treated with methods of the renal replacement therapy (RRT). Aim of the work was to determine the features ofpro- and anti-inflammatory cytokines, VEGF in patients with CKD stage V D, depending on the method of RRT (HD, HDF, PD). Materials and methods. There were examined 56 patients with CKD, st. V treated with methods of RRT: gr.1 received hemodialysis (HD) (15 p), gr. 2 - hemodiafiltration (HDF) (28 p) and gr. 3 – peritoneal dialysis (PD) (13p). The cytokines levels (IL-6, -8, -10, -18, TNF-a, VEGF) were determined in blood serum by means of ELIZA. Results. The CKD, st. V patients treated with RRT showed really increased levels of pro-inflammatory blood cytokines (TNF-a, IL-8, IL-18) (p < 0.001) and VEGF as important factor of endothelial dysfunction, in dependence on RRT the groups 1-3 did not differ (p > 0.05). In comparison with healthy donors, in patients of gr. 3 the level of antiinflammatory IL-10 was the highest (p < 0.001) in comparison with gr.1 (p = 0.080) andgr.2 (p = 0,043) (corresponding HD and HDF), and the ratio IL-18/IL-10 was really more low in comparison with both other groups (p = 0.035). Conclusion. The high level of serum cytokines confirms the SCI availability in patients with CKD,st.V; the patients treated with PD showed the lower degree of inflammatory reactions by the data of balance between pro/anti-inflammatory immunity mediators.

Authors and Affiliations

V. E. Driyanska, I. Dudar, Yu. I. Gonchar, O. Loboda, F. Z. Galsenluk, V. Krot

Keywords

Related Articles

Перитоніти, асоційовані з постійним амбулаторним перитонеальним діалізом

Інфекції, асоційовані з перитонеальним діалізом (ПД): інфекція місця виходу катетера, тунельна інфекція та перитоніт, є найбільш поширеними ускладненнями ПД. Незважаючи на значні досягнення у методичних підходах до профі...

ФАКТОР РОСТУ ФІБРОБЛАСТІВ 23 ЯК РАННІЙ МАРКЕР РОЗВИТКУ МІНЕРАЛЬНО-КІСТКОВИХ ПОРУШЕНЬ У ХВОРИХ НА ХРОНІЧНУ ХВОРОБУ НИРОК

Целью работы было изучить состояние регуляции минерального обмена при ХБП путем оценки концентрации в сыворотке крови с-концевого фрагмента ФРФ-23, ПТГ, Са, Р, а также исследовать связь между ФРФ-23 и ПТГ при ХБП. Матер...

Innovative directions of CKD prevention and treatment

Chronic kidney disease (CKD) is global challenge of health-care. Existence of CKD significantly increases total lethality risk as well as cardiovascular mortality risk. The issue is that current methodology does not ensu...

Frequency of renal dysfunction in cardiac surgery patients and its effect on outcome

The purpose of this study was to define the frequency of renal dysfunction, including acute kidney injury (AKI), in cardiac surgery patients and its effect on outcome. Materials and methods. Patients 18 years old or old...

VASCULAR ACCESS OPTIONS AT HEMODIALYSIS THERAPY INITIATION: COMPLICATIONS AND SURVIVAL OF PATIENTS WITH CHRONIC KIDNEY DISEAS STAGE 5 D

The annual increasing of dialysis population results tofocus world attention on the problems associated with improving of survival among patients with chronic kidney disease stage VD (CKD VD st.)., decreasing iatrogenic...

Download PDF file
  • EP ID EP353973
  • DOI 10.31450/ukrjnd.4(52).2016.03
  • Views 122
  • Downloads 0

How To Cite

V. E. Driyanska, I. Dudar, Yu. I. Gonchar, O. Loboda, F. Z. Galsenluk, V. Krot (2016). CYTOKINE IMMUNITYINCKD PATIENTS TREATED WITH HD, HDF, PD. УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ, 4(52), 47-51. https://europub.co.uk/articles/-A-353973